The overall structure of healthcare delivery has changed in response to the coronavirus disease 2019 (COVID-19). Besides the impact of COVID-19 on those diagnosed with the virus, it has also greatly affected patients with chronic cardiovascular illnesses that require routine visits for health maintenance. Heart failure (HF) patients need close monitoring with frequent visits to HF clinics, and at times urgent visits resulting in intravenous (IV) therapy in the ambulatory setting
